FibroTest for Evaluating Fibrosis in Non-Alcoholic Fatty Liver Disease Patients: A Systematic Review and Meta-Analysis
(1) Background: FibroTest™ is a multi-marker panel, suggested by guidelines as one of the surrogate markers with acceptable performance for detecting fibrosis in patients with non-alcoholic fatty liver disease (NAFLD). A number of studies evaluating this test have been published after publication of...
Main Authors: | Yasaman Vali, Jenny Lee, Jérôme Boursier, René Spijker, Joanne Verheij, M. Julia Brosnan, Quentin M. Anstee, Patrick M. Bossuyt, Mohammad Hadi Zafarmand, on behalf of the LITMUS Systematic Review Team |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/11/2415 |
Similar Items
-
FibroTest联合FibroScan对慢性乙型肝炎肝纤维化的诊断价值
by: CHENG Xiaojing
Published: (2014-05-01) -
Comparison of FibroTest-ActiTest with histopathology in demonstrating fibrosis and necroinflammatory activity in chronic hepatitis B and C
by: Uyar Cemile, et al.
Published: (2010-07-01) -
Liver fibrosis in young Egyptian beta-thalassemia major patients: relation to hepatitis C virus and compliance with chelation
by: Mohsen S. Elalfy, MD, PhD, et al.
Published: (2013-01-01) -
Assessment of liver fibrosis: Noninvasive means
by: Poynard Thierry, et al.
Published: (2008-01-01) -
Usefulness of acoustic radiation force impulse and fibrotest in liver fibrosis assessment after liver transplant
by: Sara Bignulin, et al.
Published: (2016-03-01)